Decreased levels of guanosine 3′, 5′‐monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2990|41|4|471-482

ISSN： 0305-1846

Source： NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol.41, Iss.4, 2015-06, pp. : 471-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis

By Iłzecka J.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 3, 2007-01 ,pp. : 264-269

Informa Healthcare

Access to resources Recommend Favorite

Serum levels of albumin‐β complexes

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 14, Iss. 3, 2014-07 ,pp. : 716-723

John Wiley & Sons Inc

Access to resources Recommend Favorite

ELEVATED CEREBROSPINAL FLUID TAU LEVELS: IMPLICATIONS FOR THE EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 8, 1996-08 ,pp. : 1012-1013

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal Fluid Markers of Alzheimer's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 10, 1991-10 ,pp. : 1025-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis

By Shimetani N.   Shimetani K.   Mori M.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 7, 2001-11 ,pp. : 567-574

Informa Healthcare

Access to resources Recommend Favorite